{"id":56688,"date":"2026-05-24T22:41:16","date_gmt":"2026-05-24T22:41:16","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&p=56688"},"modified":"2026-05-24T22:41:16","modified_gmt":"2026-05-24T22:41:16","slug":"gsk-stockmann-advises-on-the-sale-of-three-life-science-properties-in-heidelberg-technology-park","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/gsk-stockmann-advises-on-the-sale-of-three-life-science-properties-in-heidelberg-technology-park\/","title":{"rendered":"GSK Stockmann advises on the sale of three life science properties in Heidelberg Technology Park"},"content":{"rendered":"

GSK\u00a0Stockmann advised Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of Sparkasse Heidelberg, on the sale of three research and laboratory properties to GalCap Europe. The approximately 13,800 square metres of rental space are located in the \u201cIm Neuenheimer Feld\u201d technology park in Heidelberg.<\/strong><\/p>\n

<\/p>\n

A GSK\u00a0Stockmann team led by partner Dr Martin Prothmann provided Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of savings bank Sparkasse Heidelberg, with comprehensive advice on the sale.<\/p>\n

The Heidelberg Technology Park is located in the immediate vicinity of the University Hospital Heidelberg and the German Cancer Research Centre (DKFZ), placing it at the heart of one of Europe\u2019s foremost life science clusters. The properties are fully let to companies and research institutions from the biotechnology, pharmaceutical and diagnostics sectors. The site is one of Germany\u2019s central life science hubs, fostering close collaboration between university research, clinical applications and private companies.<\/p>\n

For the buyer, GalCap Europe, the transaction marks its entry into the German life science real estate market and the expansion of its portfolio, which currently comprises four properties in Austria with a market value of around EUR 100 million. Based in Vienna, GalCap Europe is a real estate asset and investment manager focusing on Austria and Central Europe.<\/p>\n

Advisers of the seller at GSK\u00a0Stockmann:<\/u><\/p>\n

Dr Martin Prothmann (lead, Real Estate Transactions & Investments), Jakob Haddad (Real Estate Transactions & Investments), Pascal Franke (Real Estate Transactions & Investments), Stephan Wachsmuth (Tax)<\/p>\n

\"\"<\/p>\n

###<\/p>\n\n\n\n
Press contact:<\/strong><\/p>\n

GSK STOCKMANN<\/p>\n

Christina Holl<\/p>\n

Karl-Scharnagl-Ring 8<\/p>\n

80539 Munich<\/p>\n

T +49 89 288174-275<\/p>\n

F +49 89 288 174-44<\/p>\n

presse@gsk.de<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt\/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective.<\/strong><\/p>\n

More about us: www.gsk.de<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-56688","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/56688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=56688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}